Streamline development processes, build better therapies for patients faster. Let's fix these challenges together! Visit our website to join the waitlist! www.cytodyme.com
"Despite advancements in automation and AI, the high variability of cell types and gene-editing techniques complicates the streamlining of production." That is only the SECOND sentence of a report that effectively summarizes why I founded Cytodyme with Tammy. The report continues to echo what those with deep knowledge of the industry have known for a long time; our infrastructure, logistics and operations are not ready for the growth the industry is about to experience. We need to advance our development and manufacturing processes at the same speed as the life saving innovation the industry is producing for patients. We need to increase the early adoption of massive cost saving automation that is available today and streamline how we build therapies. We just happen to be building the platform, tools and AI agents to do it! Read the article that explains why Cytodyme is here building everyday: https://lnkd.in/gb8g-sYF Interested in what we are cooking up? www.cytodyme.com Waitlist Open! More coming soon! #celltherapy